Serum miR-17 levels are downregulated in obese, African American women with elevated HbA1c
Purpose Type 2 diabetes is heterogeneous disease characterized by several conditions including hyperglycemia. It is estimated that over 350 million people worldwide are suffering from type 2 diabetes and this number is expected to rise. According to the CDC, African Americans were observed to have a...
Gespeichert in:
Veröffentlicht in: | Journal of diabetes and metabolic disorders 2019-06, Vol.18 (1), p.173-179 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
Type 2 diabetes is heterogeneous disease characterized by several conditions including hyperglycemia. It is estimated that over 350 million people worldwide are suffering from type 2 diabetes and this number is expected to rise. According to the CDC, African Americans were observed to have a 40% higher incidence of diabetes compared to European Americans. Epigenetic modulating mechanisms such as microRNAs (miRNAs), have recently been established as a massive regulatory machine in metabolic syndrome, obesity and type 2 diabetes. In the present study, we aimed to investigate the serum levels of circulating miRNA 17 (miR-17) of obese, African American women with elevated HbA
1c
.
Methods
We investigated miR-17 serum levels using qPCR. Then we used Pairwise Pearson Correlation Test to determine the relationship between clinical metabolic parameters and miR-17 serum levels.
Results
The results indicated that participants with elevated HbA
1c
exhibited a down regulation of serum miR-17 levels compared to participants with normal HbA
1c
. MiR-17 was also correlated with serum calcium in participants with normal HbA
1c
.
Conclusions
The results suggest that serum miR-17 is involved in the regulation of glucose and calcium homeostasis, which may contribute to the development of type 2 diabetes. |
---|---|
ISSN: | 2251-6581 2251-6581 |
DOI: | 10.1007/s40200-019-00404-3 |